## SECTION II - REPORTING TRANSPARENCY & COMPLETENESS (PRISMA-NMA)

### 4. Title & Abstract

| Item | Assessment Criterion                                                                                                                                                                    | Rating                                                                                                                                              | Evidence/Comments |
| ---- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 4.1  | **Title Identification**: Does the title identify the study as a systematic review and network meta-analysis?                                                                           | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 4.2  | **Structured Abstract**: Does the abstract provide a structured summary including background, objectives, data sources, study eligibility, synthesis methods, results, and conclusions? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 5. Introduction

| Item | Assessment Criterion                                                                                                          | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ----------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 5.1  | **Rationale**: Is the rationale for the review clearly stated, including why an NMA was necessary?                            | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 5.2  | **Objectives**: Are objectives explicitly stated with reference to participants, interventions, comparisons, outcomes (PICO)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 6. Methods - Protocol & Registration

| Item | Assessment Criterion                                                                        | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 6.1  | **Protocol Registration**: Is there indication of a registered protocol (PROSPERO, etc.)?   | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 6.2  | **Protocol Access**: Is the protocol publicly accessible with registration number provided? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 6.3  | **Protocol Deviations**: Are deviations from protocol clearly described and justified?      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 7. Methods - Eligibility Criteria

| Item | Assessment Criterion                                                                                                  | Rating                                                                                                                                              | Evidence/Comments |
| ---- | --------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 7.1  | **Study Characteristics**: Are inclusion criteria clearly specified (PICOS, follow-up, language, publication status)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 7.2  | **Eligibility Rationale**: Is rationale provided for eligibility criteria, especially restrictions?                   | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 8. Methods - Information Sources & Search

| Item | Assessment Criterion                                                                                             | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 8.1  | **Search Strategy**: Is the search strategy technically adequate and reproducible?                               | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 8.2  | **Database Coverage**: Are all relevant databases searched (MEDLINE, Embase, Cochrane, etc.)?                    | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 8.3  | **Search Dates**: Are database search dates (from-to) clearly reported?                                          | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 8.4  | **Grey Literature**: Were efforts made to identify unpublished studies (trial registries, conference abstracts)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 8.5  | **Search Strategy Documentation**: Is the full search strategy for ≥1 database provided in supplement?           | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 9. Methods - Study Selection

| Item | Assessment Criterion                                                                                 | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 9.1  | **Selection Process**: Is the study selection process clearly described (dual screening, consensus)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 9.2  | **Software Used**: Are tools for managing records documented (Covidence, DistillerSR, etc.)?         | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 10. Methods - Data Collection Process

| Item | Assessment Criterion                                                                                | Rating                                                                                                                                              | Evidence/Comments |
| ---- | --------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 10.1 | **Data Extraction**: Are data extraction methods described (forms, pilot testing, dual extraction)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 10.2 | **Contacting Authors**: Were study authors contacted for missing/unclear information?               | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 11. Methods - Data Items

| Item | Assessment Criterion                                                                                       | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 11.1 | **Extracted Variables**: Are all extracted variables listed (outcomes, moderators, study characteristics)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 11.2 | **Outcome Prioritization**: Is pre-specification of primary vs. secondary outcomes documented?             | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 12. Methods - Geometry of Network

| Item | Assessment Criterion                                                                                                | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 12.1 | **Network Diagram**: Is a network diagram presented showing all interventions and comparisons?                      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 12.2 | **Network Description**: Is there commentary on network structure (connectedness, gaps, star vs. complex networks)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 13. Methods - Risk of Bias Assessment

| Item | Assessment Criterion                                                                                               | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------------ | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 13.1 | **RoB Tool**: Is the risk of bias assessment tool specified (Cochrane RoB 2, ROBINS-I, etc.)?                      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 13.2 | **RoB Domains**: Are all relevant bias domains assessed (randomization, blinding, attrition, selective reporting)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 13.3 | **RoB Process**: Is the assessment process described (independent, dual assessment, conflict resolution)?          | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 14. Methods - Summary Measures

| Item | Assessment Criterion                                                                                                      | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 14.1 | **Effect Measure**: Is the effect measure clearly stated (OR, RR, HR, MD, SMD)?                                           | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 14.2 | **Scale Justification**: Is justification provided for the chosen scale (log-odds vs. log-risk, identity vs. logit link)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 14.3 | **Clinical Interpretation**: Are clinically important effect thresholds or minimal important differences defined?         | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 15. Methods - Statistical Model & Assumptions

| Item | Assessment Criterion                                                                                           | Rating                                                                                                                                              | Evidence/Comments |
| ---- | -------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 15.1 | **Model Description**: Is the statistical model clearly described algebraically or with appropriate citations? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 15.2 | **Fixed vs. Random**: Is the choice of fixed-effect or random-effects model justified?                         | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 15.3 | **Transitivity**: Are transitivity assumptions (similarity of effect modifiers across comparisons) discussed?  | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 15.4 | **Consistency Assumption**: Is the consistency/coherence assumption explained?                                 | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 15.5 | **Multi-Arm Trials**: Are methods for handling multi-arm trials described (accounting for correlation)?        | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 16. Methods - Inconsistency Assessment

| Item | Assessment Criterion                                                                                                                               | Rating                                                                                                                                              | Evidence/Comments |
| ---- | -------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 16.1 | **Inconsistency Methods**: Are methods to evaluate inconsistency described (loop-specific, design-by-treatment interaction, node-splitting, SIDE)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 16.2 | **Local vs. Global**: Are both local (loop-specific) and global inconsistency assessments conducted?                                               | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 17. Methods - Additional Analyses

| Item | Assessment Criterion                                                                                                          | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ----------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 17.1 | **Sensitivity Analyses**: Are sensitivity analyses pre-specified (excluding high RoB studies, alternative models, etc.)?      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 17.2 | **Meta-Regression**: If subgroup/meta-regression planned, are covariates pre-specified?                                       | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 17.3 | **Publication Bias**: Are methods to assess small-study effects/publication bias described (comparison-adjusted funnel plot)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 17.4 | **Ranking**: Are methods for ranking treatments described (SUCRA, P-scores, probability tables)?                              | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 18. Methods - Software & Implementation

| Item | Assessment Criterion                                                                                                | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 18.1 | **Software Specification**: Are software packages and versions documented (R netmeta, WinBUGS, STATA mvmeta, etc.)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 18.2 | **Code Availability**: Is statistical code made available (supplement, repository, on request)?                     | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 18.3 | **Bayesian Specifications**: If Bayesian: Are priors, MCMC specifications, convergence diagnostics reported?        | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 19. Results - Study Selection

| Item | Assessment Criterion                                                                   | Rating                                                                                                                                              | Evidence/Comments |
| ---- | -------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 19.1 | **PRISMA Flow Diagram**: Is a flow diagram showing study selection process provided?   | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 19.2 | **Exclusion Justifications**: Are reasons for exclusion at full-text stage documented? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 20. Results - Study Characteristics

| Item | Assessment Criterion                                                                                                                | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ----------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 20.1 | **Characteristics Table**: Are study characteristics clearly tabulated (design, N, population, interventions, outcomes, follow-up)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 20.2 | **Network Geometry**: Is the network geometry adequately described (number of studies per comparison, sample sizes)?                | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 20.3 | **Data Presentation**: Are included/excluded data clearly presented in tables or diagrams?                                          | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 21. Results - Risk of Bias

| Item | Assessment Criterion                                                                | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ----------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 21.1 | **RoB Summary**: Are RoB assessments summarized (table, graph, narrative)?          | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 21.2 | **Bias Impact Discussion**: Is potential impact of biases on NMA results discussed? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 22. Results - Pairwise Meta-Analysis

| Item | Assessment Criterion                                                                                       | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 22.1 | **Direct Evidence**: Are results from direct (pairwise) meta-analyses presented for available comparisons? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 23. Results - Network Meta-Analysis

| Item | Assessment Criterion                                                                                                                     | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 23.1 | **Summary Effects**: Are NMA summary relative effects presented for all comparisons with measures of uncertainty (95% CI/CrI)?           | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 23.2 | **Heterogeneity Estimates**: Are between-study variance (τ² or SD) estimates reported?                                                   | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 23.3 | **Prediction Intervals**: Are prediction intervals reported (95% PrI) to reflect uncertainty about treatment effects in future settings? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 23.4 | **Model Fit**: Are model fit statistics reported (residual deviance, DIC, I²)?                                                           | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 24. Results - Inconsistency Evaluation

| Item | Assessment Criterion                                                                                                                             | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 24.1 | **Inconsistency Results**: Are results from inconsistency assessments clearly presented (loop inconsistency factors, p-values, visual displays)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 24.2 | **Inconsistency Response**: If inconsistency detected, are appropriate actions taken (investigation, sensitivity analysis, inconsistency model)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 25. Results - Additional Analyses

| Item | Assessment Criterion                                                                            | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ----------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 25.1 | **Sensitivity Results**: Are results from sensitivity analyses reported?                        | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 25.2 | **Subgroup/Meta-Regression**: If conducted, are subgroup or meta-regression results presented?  | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 25.3 | **Treatment Rankings**: Are treatment rankings presented with appropriate uncertainty measures? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 26. Discussion - Summary of Evidence

| Item | Assessment Criterion                                                          | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ----------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 26.1 | **Key Findings**: Are principal findings clearly summarized?                  | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 26.2 | **Strength of Evidence**: Is overall strength/certainty of evidence assessed? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 27. Discussion - Limitations

| Item | Assessment Criterion                                                                                                                     | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 27.1 | **Study Limitations**: Are limitations of included studies discussed?                                                                    | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 27.2 | **Review Process Limitations**: Are limitations of the review process acknowledged (search restrictions, language, unpublished studies)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 27.3 | **Assumption Limitations**: Are limitations related to NMA assumptions (transitivity, consistency) discussed?                            | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 28. Discussion - Interpretation & Implications

| Item | Assessment Criterion                                                                                                      | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 28.1 | **Interpretation**: Are results interpreted in context of existing evidence and implications for practice/research clear? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 29. Funding & Conflicts

| Item | Assessment Criterion                                                                                       | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 29.1 | **Funding Sources**: Are funding sources for the review disclosed?                                         | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 29.2 | **Conflicts of Interest**: Are conflicts of interest declared for review authors and for included studies? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

---
